Cesarean delivery is associated with maternal and infant outcomes, but population-average estimates may obscure variation across individuals. This study examined associations between delivery mode and four maternal and infant outcomes and explored heterogeneity in estimated treatment effects. We analyzed Pregnancy Risk Assessment Monitoring System (PRAMS) data from 2016–2020, including 197,942 women with classifiable delivery modes. Least absolute shrinkage and selection operator regression was used for covariate screening, followed by extreme gradient boosting for propensity score estimation. Stabilized inverse-probability-of-treatment weights were combined with PRAMS analytic weights for population-average logistic regression. An X-learner framework was applied to explore heterogeneity in estimated treatment effects across baseline maternal and pregnancy characteristics. Compared with vaginal delivery, cesarean delivery was associated with higher odds of infant transfer (OR, 2.27; 95% CI, 1.99–2.60; p < 0.001) and postpartum depressive symptoms (OR, 1.11; 95% CI, 1.06–1.16; p < 0.001), and lower odds of breastfeeding initiation (OR, 0.85; 95% CI, 0.81–0.88; p < 0.001). The estimated odds of infant death were lower but not statistically significant (OR, 0.77; 95% CI, 0.57–1.03; p = 0.082). Exploratory X-learner analyses indicated greater heterogeneity for infant transfer and breastfeeding initiation, whereas postpartum depressive symptoms and infant death exhibited comparatively limited variability in estimated conditional effects. Cesarean delivery was associated with differential maternal and infant outcomes, with estimated heterogeneity varying across outcomes. Combining population-average regression with exploratory machine learning approaches may provide additional insight into these associations. However, residual confounding, particularly by clinical indication, and the lack of external validation limit causal interpretation and immediate clinical application.
Long COVID has been associated with elevated risks of individual chronic conditions, but its role in the transition to multimorbidity remains unclear. We analyzed MEPS Panel 24 (2019-2022) data from 4,364 adults free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-recovered, or no COVID. Discrete-time survival models estimated incident multimorbidity risk, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Long COVID was associated with a 2.54-fold higher hazard of incident multimorbidity compared with no COVID (HR = 2.54; 95% CI: 1.26-5.10), while COVID-recovered participants also had elevated hazard (HR = 1.85; 95% CI: 1.08-3.17). Incident multimorbidity onset was associated with lower physical HRQoL, increased inpatient utilization, and higher healthcare expenditures. Long COVID was independently associated with lower mental HRQoL, while evidence for Long COVID-specific expenditure growth was model-dependent. These findings suggest that Long COVID and resolved COVID-19 infection may increase the risk of transitioning into multimorbidity, supporting integrated chronic disease surveillance, mental health assessment, and coordinated post-COVID care.
Background/Objectives: Long COVID has been associated with elevated risks of individual chronic conditions, but its association with the transition to multimorbidity remains unclear. This study aims to examine whether retrospective COVID-19 status was associated with incident multimorbidity among U.S. adults. Methods: We analyzed Panel 24 of the Medical Expenditure Panel Survey (MEPS; 2019–2022), including 4356 individuals free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-19-recovered, or no COVID-19. Survey-weighted logistic regression estimated associations between retrospective COVID-19 status and incident cross-domain multimorbidity, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Results: Incident MM occurred in 106 participants: 17 with Long COVID, 41 COVID-19-recovered, and 48 with no COVID-19. In the primary model (4239 participants; 105 events), Long COVID was associated with higher odds of incident MM than no COVID-19 (OR 2.34; 95% CI, 1.14–4.79); the estimate for COVID-19-recovered participants was OR 1.71 (95% CI, 1.01–2.92). Fully adjusted and Firth estimates were directionally consistent. Cardiometabolic plus respiratory MM predominated (79/106). COVID-status-by-year interactions were not significant for total expenditures, out-of-pocket expenditures, physical or mental health scores, or inpatient stays. Conclusions: Retrospectively classified Long COVID was associated with incident cross-domain MM recorded during follow-up, but temporal ordering cannot be established, and sparse events limit precision. Replication with prospectively timed exposure and diagnosis data is needed.